Receive general news, updates and information
New Breast Surgical Guidelines
Prompt Chemotherapy Improves Outcomes
Veliparib Will be Evaluated in Phase 3 Clinical Trial
Investigational Test Provides Information about Prognosis of Early-Stage Triple-Negative Breast Cancer
Drug Combination Shows Promise Against Triple-Negative Breast Cancer
Ganetespib Shows Promise in Phase II Trial
Triple-Negative DCIS May Be More Likely to Recur
Study Explores Breast Cancer Characteristics in African-American and Hispanic/Latina Women
Triple-Negative Breast Cancer: Divide and Conquer
and Triple Negative Breast Cancer Foundation
are registered trademarks of Triple Negative Breast Cancer Foundation, Inc.
| © 2014
TNBC Foundation, Inc.